Pretoria, 03 June 2026 – The South African Health Products Regulatory Authority (SAHPRA) convened its quarterly stakeholder engagement session with “captains of industry” in Johannesburg on 14 May 2026. The meeting forms part of a structured programme of quarterly engagements that SAHPRA has maintained since...
Pretoria, 15 October 2025 – The South African Health Products Regulatory Authority (SAHPRA) and the Health Professions Council of South Africa (HPCSA) signed a Memorandum of Agreement (MOA) on 18 August 2025 for five years. The main objective of this MOA is to enable collaboration...
Pretoria, 14 September 2023 –The South African Health Products Regulatory Authority (SAHPRA) was the host country for a robust and engaging African Union Smart Safety Surveillance (AU3S) in-person Steering Group Meeting held on 11 – 12 September 2023 in Cape Town. AU-3S is a flagship...
August 30, 2023, Rockville, MD – United States Pharmacopeia (USP) welcomed an executive delegation of senior leadership from the South African Health Products Regulatory Authority (SAHPRA) to its Rockville headquarters, capping off a two-part visit from the regulator. During the visits, USP and SAHPRA exchanged...
Pretoria, 11 July 2023 -The South Africa Health Products Regulatory Authority (SAHPRA) has signed a Memorandum of Understanding (MOU) with the Egyptian Drug Authority (EDA) on 09 July at the Egyptian Embassy in Pretoria. This MOU between SAHPRA and EDA will allow for crucial collaboration and...
19 July 2022 Johannesburg – The South African Health Products Regulatory Authority (SAHPRA) and the UK’s Department for International Trade (DIT) signed a Memorandum of Understanding (MOU) today, in Sandton. The key objective of the MOU is to demonstrate the countries’ intentions to collaborate in good faith,...
